-
,for, Item ID-
- #1177628
- Quidel #M5153
Molecular Diagnostic / Real-Time RT-PCR Control Lyra® SARS-CoV-2 Positivel Level 1 mL
CONTROL, SARS COV-2 LYRA POSITIVE D/S
No Image
Features
- Lyra SARS-CoV-2 Assay is authorized for use under an FDA EUA: https://www.fda.gov/medical-devices/emergency-situations-medical-devices/emergency-use-authorizations
- Lyra SARS-CoV-2 Assay is for use only under EUA in United States (U.S.) laboratories certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C. §263a, to perform high complexity tests
- The Lyra SARS-CoV-2 Assay is a qualitative test for the detection of nucleic acid from SARSCoV-2 in NP and OP swab specimens obtained from patients suspected of COVID-19 by their healthcare provider
- More …
Product Details Email
Product Specifications
McKesson # | 1177628 |
---|---|
Manufacturer # | M5153 |
Brand | Lyra® |
Manufacturer | Quidel |
Country of Origin | United States |
Application | Control |
Container Type | Vial |
For Use With | For use with Lyra® SARS-CoV-2 Assay |
Levels | Positivel Level |
Product Dating | McKesson Acceptable Dating: we will ship >= 90 days |
Storage Requirements | Requires Refrigeration |
Test Category | Respiratory |
Test Name | SARS-CoV-2 |
Test Type | Molecular Diagnostic / Real-Time RT-PCR |
UNSPSC Code | 41116145 |
Volume | 1 mL |
Features
- Lyra SARS-CoV-2 Assay is authorized for use under an FDA EUA: https://www.fda.gov/medical-devices/emergency-situations-medical-devices/emergency-use-authorizations
- Lyra SARS-CoV-2 Assay is for use only under EUA in United States (U.S.) laboratories certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C. §263a, to perform high complexity tests
- The Lyra SARS-CoV-2 Assay is a qualitative test for the detection of nucleic acid from SARSCoV-2 in NP and OP swab specimens obtained from patients suspected of COVID-19 by their healthcare provider
- Positive results are indicative of the presence of SARS-CoV-2 RNA; clinical correlation with patient history and other diagnostic information is necessary to determine patient infection status - positive results do not rule out bacterial infection or co-infection with other viruses
- Negative results do not preclude SARS-CoV-2 infection and should not be used as the sole basis for patient management decisions; negative results must be combined with clinical observations, patient history, and epidemiological information
Professionals Also Viewed
-
,for, Item ID-
- #1113580
- Providers like you icon 265
- McKesson Brand #900-501MCK
- Used by professionals in the verification of the precision and accurac …
- 60-day open-vial stability
- Non-biohazardous
-
,for, Item ID-
- #1113579
- Providers like you icon 251
- McKesson Brand #900-503MCK
- Used by professionals in the verification of the precision and accurac …
- 60-day open-vial stability
- Non-biohazardous
-
,for, Item ID-
- #1113581
- Providers like you icon 199
- McKesson Brand #900-502MCK
- Used by professionals in the verification of the precision and accurac …
- 60-day open-vial stability
- Non-biohazardous
-
,for, Item ID-
- #763082
- Providers like you icon 503
- Hemocue #171003002
- Each Eurotrol Hemotrol control has an open-vial stability of 30 days a …
- Stable for 18 months from the date of manufacture if stored unopened i …
- Hemotrol controls may be used with Hemocue, Stat-Site, HemoPoint and H …